JP2009261329A - Cell separation device - Google Patents

Cell separation device Download PDF

Info

Publication number
JP2009261329A
JP2009261329A JP2008115590A JP2008115590A JP2009261329A JP 2009261329 A JP2009261329 A JP 2009261329A JP 2008115590 A JP2008115590 A JP 2008115590A JP 2008115590 A JP2008115590 A JP 2008115590A JP 2009261329 A JP2009261329 A JP 2009261329A
Authority
JP
Japan
Prior art keywords
cell
mesh
separation
separation device
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008115590A
Other languages
Japanese (ja)
Other versions
JP5164104B2 (en
Inventor
Masashi Emoto
正志 江本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gunma University NUC
Original Assignee
Gunma University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gunma University NUC filed Critical Gunma University NUC
Priority to JP2008115590A priority Critical patent/JP5164104B2/en
Publication of JP2009261329A publication Critical patent/JP2009261329A/en
Application granted granted Critical
Publication of JP5164104B2 publication Critical patent/JP5164104B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/04Cell isolation or sorting
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M33/00Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
    • C12M33/14Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus with filters, sieves or membranes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Sustainable Development (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a technique relating to a cell separation device using a mesh, which can be used more easily, as compared with conventional devices and having excellent durability. <P>SOLUTION: The cell separation device is provided with: a mesh-formed separation part for disintegrating a cell aggregate to separate a recovering cell from the cell aggregate and having a strength sufficient for the disintegration of the cell aggregate; a holding part to hold the outer edge of the separation part and suppress the deformation of the separation part in the case of disintegrating the cell aggregate and separating the recovering cell from the cell aggregate; and a gripping part connected to the holding part and gripped by the user. <P>COPYRIGHT: (C)2010,JPO&INPIT

Description

本発明は、細胞分離装置に関する。   The present invention relates to a cell separation device.

医療分野で行われる研究・開発では、臓器から細胞を調製することが日々行われている。臓器から細胞を調製する際に行われる、臓器の破砕や臓器からの白血球の単離には、従来、いわゆる茶漉しを代用したり、また、ステンレス製メッシュを適当な大きさに切断したものを用いたり、あるいはナイロン製のメッシュを用いていた。なお、細胞集団から特定の細胞を分離する技術としては、例えば特許文献1に記載の技術が知られている。
特開2001−178号公報
In research and development conducted in the medical field, cells are prepared daily from organs. For the disruption of organs and the isolation of leukocytes from organs, which are performed when cells are prepared from organs, conventionally, a so-called tea strainer is substituted, or a stainless steel mesh cut to an appropriate size is used. Used, or nylon mesh. As a technique for separating specific cells from a cell population, for example, a technique described in Patent Document 1 is known.
JP 2001-178 A

臓器の破砕や臓器からの白血球などの細胞の単離には、従来、いわゆる茶漉し、ステンレス製メッシュ、或いはナイロン製のメッシュが用いられていた。いわゆる茶漉しは、代用品であり、もともと臓器を破砕するためのものではないことから、完全かつ高生存率を保った白血球を分離するには不適である。また、茶漉しは、オートクレーブ処理に耐える構造になっていないことから、腐食のため、長期間繰り返し使用するには不適である。ステンレス製メッシュは、使い捨てであり、その都度メッシュを切断し、受け皿に取り付ける必要があることから、簡易な方法であるとはいい難く、肝臓のような大きな臓器を破砕するためには不適である。また、ナイロン製のメッシュは、一般に広く用いられているが、再使用ができず、また、耐久性に欠け、肝臓のような大きな臓器は破砕できない。従って、耐久性にも優れた、例えば肝臓のような比較的大きな臓器も破砕可能な細胞破砕装置の開発が望まれている。一方、近年、“地球に優しいもの”への関心が高まり、医療分野においても、医療廃棄物となるディスポーザブル製品は徐々に再利用可能なものに取って代わろうとしており、環境性にも優れた細胞分離装置が必要とされている。   Conventionally, so-called tea strainers, stainless steel meshes, or nylon meshes have been used to disrupt organs or isolate cells such as leukocytes from organs. The so-called tea strainer is a substitute and is not originally intended for crushing organs, so it is unsuitable for isolating leukocytes with a complete and high survival rate. In addition, tea strainers are not structured to withstand autoclaving and are therefore unsuitable for repeated use over a long period of time due to corrosion. Stainless steel mesh is disposable, and it is necessary to cut the mesh and attach it to the saucer each time, so it is difficult to say that it is a simple method, and it is not suitable for crushing large organs such as the liver. . Nylon meshes are generally widely used, but cannot be reused, lack durability, and cannot crush large organs such as the liver. Therefore, it is desired to develop a cell crushing apparatus that has excellent durability and can crush relatively large organs such as the liver. On the other hand, in recent years, interest in “Earth-friendly products” has increased, and in the medical field, disposable products that become medical waste are gradually being replaced by reusable products, which have excellent environmental characteristics. There is a need for a cell separator.

本発明では、上記した背景に鑑み、メッシュを用いた細胞分離装置であって、従来よりも使い易く、かつ、耐久性に優れた細胞分離装置に関する技術を提供することを課題とする。   In view of the above-described background, an object of the present invention is to provide a technique related to a cell separation apparatus using a mesh, which is easier to use than conventional ones and excellent in durability.

本発明では、上述した課題を解決するため、以下の手段を採用した。すなわち、本発明に係る細胞分離装置は細胞集合体を破砕して該細胞集合体から回収細胞を分離するメッシュ状の分離部であって、該細胞集合体を破砕するのに十分な強度を有する分離部と、前記細胞集合体を破砕して該細胞集合体から回収細胞を分離する際の前記分離部の変形を抑制する、該分離部の外縁部と接続され、該分離部を保持する保持部と、前記保持部と接続され、使用者に把持される把持部と、を備える。   In the present invention, the following means are adopted in order to solve the above-described problems. That is, the cell separation device according to the present invention is a mesh-like separation unit that crushes a cell aggregate and separates recovered cells from the cell aggregate, and has sufficient strength to crush the cell aggregate. A holding portion that is connected to an outer edge portion of the separation portion and holds the separation portion, which suppresses deformation of the separation portion when crushing the cell aggregate and separating the collected cells from the cell aggregate. And a gripping part connected to the holding part and gripped by the user.

本発明によれば、分離部が細胞集合体を破砕するのに十分な強度を有し、また、このような分離部が保持部によって保持されていることから、耐久性に優れた細胞分離装置を提供することが可能である。また、本発明に係る細胞分離装置は、保持部に把持部が接続されており、使い勝手にも優れている。   According to the present invention, since the separation unit has sufficient strength to crush the cell aggregate, and since such a separation unit is held by the holding unit, the cell separation device having excellent durability. Can be provided. In addition, the cell separation device according to the present invention has a gripping part connected to the holding part and is excellent in usability.

分離部は、細胞集合体を破砕して回収細胞を分離する。細胞集合体は、研究・開発の目的に応じて適宜選択される、ヒト、マウス、ラット等の各種臓器が例示される。回収細胞は、臓器などの細胞集合体から分離される細胞であり、白血球、肝細胞等が例示される。
回収細胞も、研究・開発の目的に応じて適宜選択され、メッシュの大きさを研究・開発の目的に応じて適宜変えることで、所望の回収細胞を分離することができる。また、本発明に係る分離部は、細胞集合体を破砕するのに十分な強度を有しており、従来、代用品として用いられていたいわゆる茶漉し等では破砕できない臓器等の破砕も可能である。分離部の材質は特に限定されるものではないが、例えば金属製とすることで、細胞集合体を破砕するのに必要とされる強度を確保することができる。
The separation unit crushes the cell aggregate and separates the recovered cells. Examples of cell aggregates include various organs such as humans, mice, and rats, which are appropriately selected according to the purpose of research and development. The collected cells are cells separated from cell aggregates such as organs, and examples include leukocytes and hepatocytes.
Recovered cells are also appropriately selected according to the purpose of research and development, and desired recovered cells can be separated by appropriately changing the size of the mesh according to the purpose of research and development. In addition, the separation unit according to the present invention has sufficient strength to crush cell aggregates, and can crush organs that cannot be crushed by so-called tea strainers that have been used as substitutes in the past. is there. The material of the separation part is not particularly limited, but, for example, by using a metal, it is possible to ensure the strength required for crushing the cell aggregate.

ここで、細胞集合体を破砕する際には、該細胞集合体がメッシュを有する分離部の表面と略直交する方向に押し付けられる。つまり、細胞集合体を破砕する際、メッシュには、所定の力が加えられる。そして、細胞集合体が押し付けられた際に分離部が変形してしまうと、細胞集合体を効果的に破砕することができない虞がある。そこで、本発明に係る細胞分離装置では、保持部によって、分離部の外縁部を保持することとした。これにより、細胞集合体を破砕して該細胞集合体から回収細胞を分離す際に起こりうる分離部の変形が抑制される。すなわち、分離部の外縁部が保持部と接続されることで、分離部に細胞集合体が押し付けられた際、分離部には引張力が作用し、撓みが低減される。その結果、細胞集合体の分離をより確実に行うことが可能となる。なお、従来技術では、ステンレス製メッシュをその都度切断し、受け皿に取り付ける必要があり、煩わしい作業が必要とされ、また、受け皿への取り付け状態が不十分であると、破砕を確実に行えないといったことも懸念されていた。一方、本発明に係る細胞分離装置によれば、このような問題も解消することができる。   Here, when the cell aggregate is crushed, the cell aggregate is pressed in a direction substantially orthogonal to the surface of the separation part having a mesh. That is, when the cell aggregate is crushed, a predetermined force is applied to the mesh. If the separation part is deformed when the cell aggregate is pressed, the cell aggregate may not be effectively crushed. Therefore, in the cell separation device according to the present invention, the outer edge portion of the separation portion is held by the holding portion. Thereby, the deformation | transformation of the isolation | separation part which may occur when crushing a cell aggregate and isolate | separating a collection | recovery cell from this cell aggregate is suppressed. That is, by connecting the outer edge part of the separation part to the holding part, when the cell aggregate is pressed against the separation part, a tensile force acts on the separation part, and bending is reduced. As a result, the cell aggregate can be more reliably separated. In the prior art, it is necessary to cut the stainless steel mesh each time and attach it to the saucer, which requires troublesome work. Also, if the attachment state to the saucer is insufficient, crushing cannot be performed reliably. There was also concern. On the other hand, according to the cell separation device of the present invention, such a problem can be solved.

把持部は、保持部に接続され、使用者(細胞分離装置を使用する者)に把持される。把持部の形状は、特に限定されないが、使用者が安定的に把持できる長さを有することが好ましく、安定的に把持可能な長さとすることで操作性をより向上させることができる。また、把持部にある程度の幅や厚みを持たせることで、より把持しやすい把持部とすることができる。なお、従来のその都度切断するステンレス製のメッシュやナイロン製のメッシュには把持部が設けられていないため、直接分離部を把持しなければならず、操作性が悪い。また、このような従来態様では空気中に存在する微生物が混入してしまうことも懸念される。これに対し、本発明に係る細胞分離装置は、ある程度の長さを有する把持部を備えることで、分離部と使用者が把持する部分までの距離を確保することができる。その結果、細胞集合体の破砕を、回収細胞に空気中の微生物等が混入しないように分離部の周囲を外部から隔離した状態で行うことが可能となる。つまり、集合細胞体を無菌的に取り扱うことが可能となる。従って、本発明に係る把持部は、その長さを空気中に存在する微生物の混入を抑制可能な長さに設計してもよい。   The grip portion is connected to the holding portion and is gripped by a user (a person who uses the cell separation device). The shape of the grip portion is not particularly limited, but it is preferable that the grip portion has a length that can be stably gripped by the user, and the operability can be further improved by using a length that can be stably gripped. Moreover, it can be set as the holding part which is easier to hold | grip by giving a certain width and thickness to a holding part. In addition, since the conventional stainless steel mesh or nylon mesh that is cut each time is not provided with a gripping portion, the separation portion must be gripped directly, resulting in poor operability. Moreover, in such a conventional mode, there is a concern that microorganisms present in the air are mixed. On the other hand, the cell separation device according to the present invention includes a gripping portion having a certain length, thereby ensuring a distance from the separation portion to a portion gripped by the user. As a result, the cell aggregate can be crushed in a state in which the periphery of the separation unit is isolated from the outside so that microorganisms in the air do not enter the collected cells. That is, the aggregated cell body can be handled aseptically. Therefore, you may design the holding | grip part which concerns on this invention in the length which can suppress mixing of the microorganisms which exist in the air.

ここで、上述した細胞分離装置において、前記細胞集合体を破砕して該細胞集合体から回収細胞を分離する際の該回収細胞の損傷を抑制するように、メッシュを構成する複数の線部材の夫々が面取り構造を有することが好ましい。これにより、本発明に係る細胞分離装置によれば、回収細胞を分離する際の回収細胞の損傷を防止することが可能となる。その結果、例えば、回収細胞として白血球を調製する場合では、非常に生存率の高い白血球を調製することが可能となる。   Here, in the cell separation apparatus described above, a plurality of wire members constituting the mesh are configured to suppress damage to the collected cells when the cell aggregates are crushed and the collected cells are separated from the cell aggregates. Each preferably has a chamfered structure. Thereby, according to the cell separation device concerning the present invention, it becomes possible to prevent the recovery cell from being damaged when the recovery cell is separated. As a result, for example, when leukocytes are prepared as recovered cells, leukocytes with a very high survival rate can be prepared.

また、上述した本発明に係る細胞分離装置において、前記分離部は、外縁部が折り曲げられ、前記保持部は、前記把持部が接続される第一リング部材と、該第一リング部材の内径より僅かに小さい外径の第二リング部材と、を有し、第一リング部材の内側面と第二リング部材の外側面との間に前記折り曲げられた外縁部を挟持することで、前記分離部を保持するようにしてもよい。このような構成とすることで、分離部を安定的に保持することが可能となる。   Further, in the above-described cell separation device according to the present invention, the separation part is bent at an outer edge part, and the holding part includes a first ring member to which the grip part is connected and an inner diameter of the first ring member. A second ring member having a slightly smaller outer diameter, and sandwiching the bent outer edge between the inner surface of the first ring member and the outer surface of the second ring member, thereby May be held. With this configuration, it is possible to stably hold the separation unit.

なお、上述した本発明に係る細胞分離装置の各構成、すなわち、前記分離部、前記保持
部、及び前記把持部は、オートクレーブ処理に耐え得る金属製部材によって構成することが好ましい。また、前記分離部、前記保持部、及び前記把持部は、ステンレス製とすることがより好ましい。金属製とすることで、従来のナイロン製のメッシュに比べて耐久性を向上させることができる。また、オートクレーブ処理により、再利用が可能となり、環境性にも優れた細胞分離装置を提供することができる。また、本発明に係る細胞分離装置は、種々の消毒薬に対して殆ど腐食することも無く、火炎滅菌を施すことも可能となる。更に、本発明に係る細胞分離装置によれば、十分な強度と耐久性を有することから、脾臓などの比較的小さい臓器のみならず、肝臓のように比較的大きい臓器も短時間で破砕することができる。
In addition, it is preferable that each structure of the cell separation apparatus which concerns on this invention mentioned above, ie, the said separation part, the said holding | maintenance part, and the said holding part, is comprised with the metal members which can endure an autoclave process. More preferably, the separation part, the holding part, and the grip part are made of stainless steel. By making it metal, durability can be improved compared with the conventional nylon mesh. In addition, the autoclave treatment can be reused, and a cell separation apparatus excellent in environmental performance can be provided. In addition, the cell separation device according to the present invention is hardly corroded with respect to various disinfectants and can be subjected to flame sterilization. Furthermore, according to the cell separation device of the present invention, since it has sufficient strength and durability, not only relatively small organs such as the spleen but also relatively large organs such as the liver can be crushed in a short time. Can do.

本発明によれば、メッシュを用いた細胞分離装置であって、従来よりも使い易く、かつ、耐久性に優れた細胞分離装置に関する技術を提供することができる。   ADVANTAGE OF THE INVENTION According to this invention, it is a cell separation apparatus using a mesh, Comprising: The technique regarding the cell separation apparatus which was easier to use than before, and was excellent in durability can be provided.

次に、本発明に係る細胞分離装置の実施形態について図面に基づいて説明する。   Next, an embodiment of a cell separation device according to the present invention will be described based on the drawings.

<構成>
図1は、実施形態に係る細胞分離装置の平面図を示し、図2は、実施形態に係る細胞分離装置の側面図を示す。また、図3は、実施形態に係る細胞分離装置の分解斜視図を示す。これらの図に示すように、実施形態に係る細胞分離装置100は、メッシュ1、第一リング2、第二リング3、把持部4によって構成されている。以下、各構成について説明する。
<Configuration>
FIG. 1 shows a plan view of the cell separation device according to the embodiment, and FIG. 2 shows a side view of the cell separation device according to the embodiment. FIG. 3 is an exploded perspective view of the cell separation device according to the embodiment. As shown in these drawings, the cell separation device 100 according to the embodiment includes a mesh 1, a first ring 2, a second ring 3, and a grip portion 4. Each configuration will be described below.

メッシュ1は、本発明の分離部に相当し、ヒト、マウス、ラット等の各種臓器といった細胞集合体を破砕して回収細胞(例えば、白血球)を分離する。細胞集合体及び回収細胞は、研究・開発の目的に応じて適宜選択されることから、メッシュの大きさやメッシュの種類も研究・開発の目的に基づいて調製すればよい。本実施形態のメッシュ1は、細胞集合体を分離する底部11と、第一リング2と第二リング3によって狭持される接続部12(図3参照)によって構成されている。本実施形態の底部11は、円形であり、また、細胞集合体を挿入する方向に湾曲しており、破砕・分離がより確実に行えるよう工夫されている。また、接続部12は、底部11の外縁部を上方に折り曲げることで形成されており、接続部12と底部11は一体的に形成されている。   The mesh 1 corresponds to a separation unit of the present invention, and crushes cell aggregates such as various organs such as humans, mice, and rats, and separates recovered cells (for example, white blood cells). Since cell aggregates and recovered cells are appropriately selected according to the purpose of research and development, the size of the mesh and the type of mesh may be prepared based on the purpose of research and development. The mesh 1 according to the present embodiment includes a bottom 11 that separates cell aggregates, and a connection portion 12 (see FIG. 3) that is sandwiched between the first ring 2 and the second ring 3. The bottom portion 11 of the present embodiment is circular and is curved in the direction in which the cell aggregate is inserted, and is devised so that crushing and separation can be performed more reliably. Moreover, the connection part 12 is formed by bending the outer edge part of the bottom part 11 upwards, and the connection part 12 and the bottom part 11 are formed integrally.

なお、本実施形態では、メッシュ1をステンレス製としたが、材質、メッシュを構成する線径、目合は、破砕する臓器や回収する細胞に応じて適宜選択すればよい。例えば、材質には、ステンレスの他、ニッケル、モネル、黄銅、丹銅、燐青銅、銅、鉄、亜鉛引鉄線、鋼、アルミニウム、チタン、ニクロム、ハステロイ、インコネル等を用いることができる。また、ステンレスには、SUS304、SUS316、SUS316L、SUS430、SUS310S等が例示される。   In this embodiment, the mesh 1 is made of stainless steel, but the material, the diameter of the wire constituting the mesh, and the degree of mesh may be appropriately selected according to the organ to be crushed and the cells to be collected. For example, nickel, monel, brass, red brass, phosphor bronze, copper, iron, galvanized wire, steel, aluminum, titanium, nichrome, hastelloy, inconel, etc. can be used as the material. Examples of stainless steel include SUS304, SUS316, SUS316L, SUS430, and SUS310S.

線径は、織金網として通常使用される0.02mmから2.00mmとすることが好ましい。
目合とは、メッシュ(一辺における25.4mm間の目数)或いは、開き目(空間)である。開き目(mm)は、式1により、空間率(%)は、式2により算出される。
開き目=25.4/メッシュ−線径・・・式1
空間率=(開き目)2/(開き目+線径)2×100・・・式2
目合は細胞の種類に応じて選択すればよいが、50〜80メッシュが好ましい。
The wire diameter is preferably 0.02 mm to 2.00 mm, which is usually used as a woven wire mesh.
The mesh is a mesh (number of meshes between 25.4 mm on one side) or an open mesh (space). The opening (mm) is calculated by Equation 1, and the space ratio (%) is calculated by Equation 2.
Opening = 25.4 / mesh-wire diameter: Formula 1
Space ratio = (opening) 2 / (opening + wire diameter) 2 × 100 Formula 2
The degree of mesh may be selected according to the cell type, but 50 to 80 mesh is preferable.

メッシュは金属の薄板に小孔をプレスして形成されるものでもよいが、ステンレスなど
の金属線を織って作製されたものであることが好ましい。織方には、平織(PLAIN WEAVE)、綾織(TWILLED WEAVE)、撚線織(STAND WEAVE)、杉綾織(HERRINGBONE TWILLED WEAVE)、繻子織(SATIN WEAVE)、平畳織(PLAIN DUTCH WEAVE)、綾畳織(TWILLED DUTCH
WEAVE)、逆畳織(REVERSE DUTCH WEAVE)、延織(STRAND TWILLED WEAVE)、鎖状縦三本織(TRIPLE WARP WEAVE)、スダレ織(TIRE FABRIC WEAVE)が例示される。
The mesh may be formed by pressing small holes in a thin metal plate, but is preferably produced by weaving a metal wire such as stainless steel. For weaving, weaving is plain weaving (PLAIN WEAVE), twill weaving (TWILLED WEAVE), twisted weaving (STAND WEAVE), Aya Sugi (HERRINGBONE TWILLED WEAVE), satin weaving (SATIN WEAVE), flat weaving (PLAIN DUTCH WEAVE), twill Tatami weave (TWILLED DUTCH
WEAVE), REVERSE DUTCH WEAVE, STRAND TWILLED WEAVE, TRIPLE WARP WEAVE, and TIRE FABRIC WEAVE.

ここで、図4は、メッシュ1を平織とした場合のメッシュ1の拡大図を示す。また、図5は、メッシュ1を綾織とした場合のメッシュ1の拡大図を示す。平織は、織金網の標準的な織方であり、縦線と横線とが一定の間隔をあけて配置されており、一本ずつ相互に交わるように構成されている。また、綾織は、平織では織り難い様な比較的ハイメッシュや網目の割りに線径が太い金網を織る場合に用いられる。綾織では、縦線と横線とが一定の間隔をあけて配置され、相互に二本以上ずつ乗り越して交わっている。また、本実施形態では、メッシュを構成する縦線、横線が面取りされている。これにより、回収細胞を分離する際の回収細胞の損傷を防止することが可能となる。その結果、例えば、回収細胞として白血球を調製する場合では、非常に生存率の高い白血球を調製することが可能となる。   Here, FIG. 4 shows an enlarged view of the mesh 1 when the mesh 1 is a plain weave. FIG. 5 shows an enlarged view of the mesh 1 when the mesh 1 is a twill weave. The plain weave is a standard weaving method of the woven wire mesh, and the vertical lines and the horizontal lines are arranged at a predetermined interval and are configured to cross each other one by one. Twill weave is used when weaving a relatively high mesh or a wire mesh with a large wire diameter for a mesh that is difficult to weave with a plain weave. In twill weaving, vertical lines and horizontal lines are arranged at regular intervals and cross over each other by two or more. Moreover, in this embodiment, the vertical line and horizontal line which comprise a mesh are chamfered. This makes it possible to prevent damage to the collected cells when separating the collected cells. As a result, for example, when leukocytes are prepared as recovered cells, leukocytes with a very high survival rate can be prepared.

第一リング2と第二リング3は、本発明の保持部に相当する。第一リング2は、環状のステンレス製部材によって構成されており、外側面に把持部4が接続されている。第二リング3も、環状のステンレス製部材によって構成されている。第二リング3の外径は、第一リング2の内径より僅かに小さく設計され、第一リング2の内側面と第二リング3の外側面との間にメッシュ1の接続部12が挟持される。このようにメッシュ1の接続部12が第一リング2と第二リング3によって保持されることで、細胞集合体が押し付けられた際、メッシュ1には引張力が作用し、撓みが低減され、その結果、細胞集合体の分離をより確実に行うことが可能となる。第一リング2と第二リング3は、分解可能な構成としてもよく、また、既存の接着剤等によって固定するようにしてもよい。前者によれば、メッシュ1の着脱が可能となり、後者によれば、より安定的にメッシュ1を保持することが可能となる。   The first ring 2 and the second ring 3 correspond to the holding portion of the present invention. The 1st ring 2 is comprised by the cyclic | annular stainless steel member, and the holding part 4 is connected to the outer surface. The second ring 3 is also composed of an annular stainless steel member. The outer diameter of the second ring 3 is designed to be slightly smaller than the inner diameter of the first ring 2, and the connecting portion 12 of the mesh 1 is sandwiched between the inner surface of the first ring 2 and the outer surface of the second ring 3. The Thus, when the cell assembly is pressed by holding the connection portion 12 of the mesh 1 by the first ring 2 and the second ring 3, a tensile force acts on the mesh 1 and the deflection is reduced. As a result, the cell aggregate can be more reliably separated. The first ring 2 and the second ring 3 may be configured to be disassembled, or may be fixed with an existing adhesive or the like. According to the former, the mesh 1 can be attached and detached, and according to the latter, the mesh 1 can be held more stably.

把持部4は、棒状のステンレス製部材からなり、第一リング2の外側面に接続されている。本実施形態の把持部4は、一本のステンレス製の棒状部材が略中央で折り返すように折り曲げられ、折り返された自由端部41から接続端部42に向かって、並行する棒状部材の間隔が徐々に広くなるように設計されている。そして、並行する棒状部材の夫々の自由端部42が、第一リング2の外側面に溶接接続されている。また、自由端部41の近傍には、折曲部43が設けられている。この折曲部43を基点として、自由端部41が斜め下方向を指すように把持部4の自由端部41側が折り曲げられることで、本実施形態の細胞分離装置100は、より把持しやいように工夫されている。また、把持部4は、使用者が安定的に把持できる長さ(本実施形態では、メッシュ1の中央から把持部4の自由端部41までの長さが約140mm)に設計されている。更に、把持部4が十分な長さを有することで、本実施形態の細胞分離装置100によれば、破壊・分離する細胞集合体を無菌的に取り扱うことも可能である。   The grip portion 4 is made of a rod-shaped stainless steel member and is connected to the outer surface of the first ring 2. The grip portion 4 of the present embodiment is bent so that one stainless rod-shaped member is folded at a substantially center, and the interval between the parallel rod-shaped members from the folded free end portion 41 toward the connection end portion 42 is increased. Designed to gradually widen. The free end portions 42 of the parallel bar-like members are welded to the outer surface of the first ring 2. Further, a bent portion 43 is provided in the vicinity of the free end portion 41. The cell separation device 100 of the present embodiment is more easily gripped by bending the free end 41 side of the grip portion 4 so that the free end 41 points obliquely downward with the bent portion 43 as a base point. It has been devised. The grip 4 is designed to have a length that can be stably gripped by the user (in this embodiment, the length from the center of the mesh 1 to the free end 41 of the grip 4 is about 140 mm). Furthermore, since the holding part 4 has a sufficient length, according to the cell separation device 100 of the present embodiment, it is possible to aseptically handle the cell aggregate to be destroyed and separated.

<実施例>
次に上述した実施形態の細胞分離装置100を用いた実施例について説明する。なお、以下に説明する実施例では、細胞分離装置100に平織のメッシュ(図4参照。)を用いた。また、メッシュ1の材質には、SUS304を採用し、メッシュ1の底部11の径を50mmとした。
<Example>
Next, examples using the cell separation device 100 of the above-described embodiment will be described. In the examples described below, a plain weave mesh (see FIG. 4) was used for the cell separation device 100. Moreover, SUS304 was employ | adopted for the material of the mesh 1, and the diameter of the bottom part 11 of the mesh 1 was 50 mm.

(施設・設備)
場所:群馬大学医学部保健学科中央棟5階、感染・免疫系演習室、感染・免疫系実験室、感染・免疫・血液系実習室
設備:クリーンベンチ(日立・CCV-1301EC)、安全キャビネット(昭和科学・SEC2A-1300V)、遠心機(ベックマン・Allegra-GKR)
場所:群馬大学医学部臨床研究棟4階 臓器病態制御系病態腫瘍制御学講座腫瘍放射線学
設備:フローサイトメーター(FACSCallibur) (BD Biosciences)
(Facility / equipment)
Venue: Gunma University School of Health, Central Building, 5th floor, Infection / Immune System Exercise Room, Infection / Immune System Laboratory, Infection / Immunology / Blood Laboratory Room: Clean Bench (Hitachi / CCV-1301EC), Safety Cabinet (Showa) Science / SEC2A-1300V), Centrifuge (Beckman / Allegra-GKR)
Venue: Gunma University School of Medicine, Clinical Research Building, 4th floor Organ Pathology Control Pathology Tumor Control Laboratory Tumor Radiology Equipment: Flow cytometer (FACSCallibur) (BD Biosciences)

(抗体)
FITC標識CD3ε・(145-2C11)、ビオチン標識NK1.1 (PK136)、並びにFcγ・receptor (R)
(2.4G2) に対するモノクローナル抗体 (mAb)はBD PharMingen (Hamburg, Germany) より購入したものを実験に供した。
(antibody)
FITC-labeled CD3ε (145-2C11), biotin-labeled NK1.1 (PK136), and Fcγ-receptor (R)
A monoclonal antibody (mAb) against (2.4G2) purchased from BD PharMingen (Hamburg, Germany) was used for the experiment.

(試薬)
牛胎児血清 (FCS) はTrace Biosciences (Castle Hill, HSW, Australia)、Percoll (比重:1.124g/ml) はBiochrom (Berlin, Germany)、RPMI 1640はNISSUI PHAMACEUTICAL CO., LTD (Tokyo, Japan)、HEPESはDOJINDO LABORATORIES (Kumamoto, Japan)、L-glutamine及びpenicillin / streptomycinはInvitrogen (Carlsbad, CA, USA) より、2-mercaptoethanol、sodium hydrogen carbonate、ammonium chloride、TRIS及びsodium azideはWako Pure Chemical Industries, Ltd. (Osaka, Japan) より、Bovine serum albmin (BSA) はThermo (Hamilton, New Zealand)より、streptavidin (SA) 標識Cy5はBD PharMingenより、paraformaldehyde (PFA) はMerck (Darmstadt, Germany) より購入したものを実験に供した。
(reagent)
Fetal bovine serum (FCS) is Trace Biosciences (Castle Hill, HSW, Australia), Percoll (specific gravity: 1.124 g / ml) is Biochrom (Berlin, Germany), RPMI 1640 is NISUI PHAMACEUTICAL CO., LTD (Tokyo, Japan), HEPES is from DOJINDO LABORATORIES (Kumamoto, Japan), L-glutamine and penicillin / streptomycin are from Invitrogen (Carlsbad, CA, USA), 2-mercaptoethanol, sodium hydrogen carbonate, ammonium chloride, TRIS and sodium azide are from Wako Pure Chemical Industries, Ltd. (Osaka, Japan), Bovine serum albmin (BSA) from Thermo (Hamilton, New Zealand), streptavidin (SA) labeled Cy5 from BD PharMingen, paraformaldehyde (PFA) from Merck (Darmstadt, Germany) Was subjected to the experiment.

(肝内白血球の調製)
日本チャールズリバー(横浜)より購入し、群馬大学医学部附属動物実験施設においてspecific pathogen-free環境下で飼育・交配したC57BL/6マウス(8〜12週齢の雄または雌)を頚椎脱臼もしくはジエチルエーテルにより安楽死させた後、肝臓を摘出した。肝臓はcomplete medium (CM: 20 mM HEPES・10% sodium hydrogen carbonate・L-glutamine (293μg/ml)・penicillin (100U/ml)・streptomycin (100μg/ml)・FCS (10%)・2-mercaptoetanol (50mM)含有RPMI 1640培地)にて潅流後、上述した実施形態の細胞分離装置100(平織メッシュ、SUS304)で分離し、細胞浮遊液を500 rpm・20秒間遠心分離した。上清を1500 rpm・5分間遠心分離後、沈渣に40 % percoll(CMで希釈)を加え、70 % percoll(CMで希釈)に重層した。1800 rpm・23分間遠心分離した後、40 % 並びに70 % percollの中間層を回収した。Lysis buffer (蒸留水にNH4Cl 8.3 mgを溶解し0.17 M Tris buffer (pH 7.65) 111 mlを加えたもの) により溶血後、CMにて洗浄し1 × 106 /mlとなるように細胞をCMに浮遊した。
(Preparation of intrahepatic leukocytes)
C57BL / 6 mice (8-12 weeks old male or female) purchased from Charles River Japan (Yokohama), bred and bred in a specific pathogen-free environment at the Gunma University School of Medicine Animal Experiment Facility or cervical dislocation or diethyl ether The liver was removed after euthanization. Liver is complete medium (CM: 20 mM HEPES, 10% sodium hydrogen carbonate, L-glutamine (293 μg / ml), penicillin (100 U / ml), streptomycin (100 μg / ml), FCS (10%), 2-mercaptoetanol ( After perfusion with a 50 mM) -containing RPMI 1640 medium), the cells were separated by the cell separation apparatus 100 (plain weave mesh, SUS304) of the above-described embodiment, and the cell suspension was centrifuged at 500 rpm for 20 seconds. The supernatant was centrifuged at 1500 rpm for 5 minutes, 40% percoll (diluted with CM) was added to the sediment, and the mixture was overlaid with 70% percoll (diluted with CM). After centrifugation at 1800 rpm for 23 minutes, an intermediate layer of 40% and 70% percoll was recovered. After hemolysis with Lysis buffer (8.3 mg NH 4 Cl dissolved in distilled water and 111 ml 0.17 M Tris buffer (pH 7.65)), the cells were washed with CM and the cells were adjusted to 1 × 10 6 / ml. Floating on CM.

(フローサイトメトリー)
抗体の非特異的結合を防ぐため、細胞を抗FcγR (2.4G2) mAbと4℃・15分間反応させた後、FITC・Biotin標識mAbと4℃・15分間反応させた。Biotin標識抗体はSA-標識Cy5(BD ParMingen)にて視覚化した。染色後、細胞を1 % PFA含有PBS (-) で固定後、FACSCalibur (BD PharMingen)により取り込み、CellQuest software(BD PharMingen)により解析した。
(Flow cytometry)
In order to prevent non-specific binding of the antibody, the cells were reacted with anti-FcγR (2.4G2) mAb at 4 ° C. for 15 minutes and then reacted with FITC / Biotin-labeled mAb at 4 ° C. for 15 minutes. Biotin-labeled antibodies were visualized with SA-labeled Cy5 (BD ParMingen). After staining, the cells were fixed with 1% PFA-containing PBS (−), taken up with FACSCalibur (BD PharMingen), and analyzed with CellQuest software (BD PharMingen).

(効果)
ここで、表1は、従来のナイロンメッシュと本実施例における回収細胞数の比較表を示す。図6は、本実施例によるフローサイトメーターの結果を示す。また、表2は、従来のナイロンメッシュと本実施例の細胞分離装置の比較表を示す。表1に示すように、本実施例における回収細胞数は、従来のナイロンメッシュによる回収細胞数を上回っている。また、図6に示すように、T細胞、NKT細胞、NK細胞が、上記細胞分離装置100を用いることにより、非常に効率よく分離されていることがわかる。また、表2に示すように、実施例の細胞分離装置は、従来のナイロンメッシュと比較して、大きさ、再利用性、耐久性、使い易さ、細胞回収率の点で優れた効果を奏する。なお、経済性(コスト)についても、
本実施例の細胞分離装置は、再利用可能であることから、ランニングコストを低減することが可能である。
(effect)
Here, Table 1 shows a comparison table of the number of recovered cells in the conventional nylon mesh and this example. FIG. 6 shows the results of the flow cytometer according to this example. Table 2 shows a comparison table between the conventional nylon mesh and the cell separation device of this example. As shown in Table 1, the number of recovered cells in this example exceeds the number of recovered cells by the conventional nylon mesh. In addition, as shown in FIG. 6, it can be seen that T cells, NKT cells, and NK cells are separated very efficiently by using the cell separation device 100. In addition, as shown in Table 2, the cell separation device of the example has superior effects in terms of size, reusability, durability, ease of use, and cell recovery rate as compared with the conventional nylon mesh. Play. Regarding economic efficiency (cost),
Since the cell separation device of the present embodiment is reusable, it is possible to reduce the running cost.

Figure 2009261329
Figure 2009261329

Figure 2009261329
Figure 2009261329

以上説明した実施形態の細胞分離装置100によれば、利便性、作業性、耐久性を向上することができる。より詳細には、従来のナイロン製のメッシュに比べて耐久性を向上させることができる。また、オートクレーブ処理をかけることで、再利用が可能となり、環境性にも優れた細胞分離装置を提供することができる。また、上記細胞分離装置100は、種々の消毒薬に対して殆ど腐食することも無く、火炎滅菌を施すことも可能となる。更に、上記細胞分離装置100は十分な強度と耐久性を有することから、脾臓などの比較的小さい臓器のみならず、肝臓のように比較的大きい臓器も短時間で破砕することができる。   According to the cell separation device 100 of the embodiment described above, convenience, workability, and durability can be improved. More specifically, the durability can be improved as compared with a conventional nylon mesh. In addition, by applying autoclaving, it is possible to provide a cell separation device that can be reused and is excellent in environmental performance. Further, the cell separation device 100 is hardly corroded against various disinfectants and can be subjected to flame sterilization. Furthermore, since the cell separator 100 has sufficient strength and durability, not only a relatively small organ such as the spleen but also a relatively large organ such as the liver can be crushed in a short time.

また、実施形態の細胞分離装置は、微生物混入の危険性を最小限に留め、臓器を簡易かつ効率よく破砕し、生存率の高い細胞を回収するための簡易ツールとして多くの施設で利用することができる。また、研究機関を含む医療分野においては、臓器から細胞を調製す
ることなく、研究・開発を進めることは困難である。そのため、上記細胞分離装置は、病院等の診療施設、臨床検査受託センター、医療系大学及び研究機関並びに製薬会社等の企業において、広く使用することができる。
In addition, the cell separation device of the embodiment is used in many facilities as a simple tool for minimizing the risk of microbial contamination, crushing organs easily and efficiently, and recovering cells with high survival rate. Can do. In the medical field including research institutions, it is difficult to advance research and development without preparing cells from organs. Therefore, the cell separation device can be widely used in medical facilities such as hospitals, clinical laboratory contract centers, medical universities and research institutions, and companies such as pharmaceutical companies.

なお、以上本発明の好適な実施形態を説明したが、本発明に係る細胞分離装置はこれらに限らず、可能な限りこれらの組合せを含むことができる。   Although the preferred embodiments of the present invention have been described above, the cell separation device according to the present invention is not limited to these, and can include combinations thereof as much as possible.

実施形態に係る細胞分離装置の平面図を示す。The top view of the cell separation device concerning an embodiment is shown. 実施形態に係る細胞分離装置の側面図を示す。The side view of the cell separation device concerning an embodiment is shown. 実施形態に係る細胞分離装置の分解斜視図を示す。The disassembled perspective view of the cell separation device concerning an embodiment is shown. メッシュを平織とした場合のメッシュの拡大図を示す。An enlarged view of the mesh when the mesh is a plain weave is shown. メッシュを綾織とした場合のメッシュの拡大図を示す。An enlarged view of the mesh when the mesh is a twill weave is shown. 本実施例によるフローサイトメトリーの結果を示す。The result of the flow cytometry by a present Example is shown.

符号の説明Explanation of symbols

1・・・メッシュ
2・・・第一リング
3・・・第二リング
4・・・把持部
11・・・底部
12・・・接続部
41・・・自由端部
42・・・接続端部
43・・・折曲部
100・・・細胞分離装置
DESCRIPTION OF SYMBOLS 1 ... Mesh 2 ... 1st ring 3 ... 2nd ring 4 ... Grasp part 11 ... Bottom part 12 ... Connection part 41 ... Free end part 42 ... Connection end part 43 ... Bending part 100 ... Cell separation device

Claims (4)

細胞集合体を破砕して該細胞集合体から回収細胞を分離するメッシュ状の分離部であって、該細胞集合体を破砕するのに十分な強度を有する分離部と、
前記細胞集合体を破砕して該細胞集合体から回収細胞を分離する際の前記分離部の変形を抑制する、該分離部の外縁部を保持する保持部と、
前記保持部と接続され、使用者に把持される把持部と、
を備える細胞分離装置。
A mesh-like separation unit for crushing the cell aggregate and separating the recovered cells from the cell aggregate, the separation unit having sufficient strength to crush the cell aggregate;
A holding part for holding the outer edge part of the separation part, which suppresses deformation of the separation part when crushing the cell aggregate and separating the recovered cells from the cell aggregate;
A gripping part connected to the holding part and gripped by a user;
A cell separation apparatus comprising:
前記分離部は、前記細胞集合体を破砕して該細胞集合体から回収細胞を分離する際の該回収細胞の損傷を抑制するように、メッシュ状の分離部を構成する複数の線部材の夫々が面取り構造を有する請求項1に記載の細胞分離装置。   Each of the plurality of line members constituting the mesh-like separation unit is configured to suppress damage of the collected cells when the separated cells are crushed and the collected cells are separated from the cell aggregate. The cell separation device according to claim 1, which has a chamfered structure. 前記分離部は、外縁部が折り曲げられ、
前記保持部は、前記把持部が接続される第一リング部材と、該第一リング部材の内径より僅かに小さい外径の第二リング部材と、を有し、第一リング部材の内側面と第二リング部材の外側面との間に前記折り曲げられた外縁部を挟持することで前記分離部を保持する請求項1又は請求項2に記載の細胞分離装置。
The separating portion is bent at the outer edge,
The holding portion includes a first ring member to which the grip portion is connected, and a second ring member having an outer diameter slightly smaller than the inner diameter of the first ring member, and an inner surface of the first ring member; The cell separation device according to claim 1 or 2, wherein the separation part is held by sandwiching the bent outer edge part between the outer side surface of the second ring member.
前記分離部、前記保持部、及び前記把持部は、オートクレーブ処理に耐え得る金属製部材からなる請求項1から請求項3の何れか一に記載の細胞分離装置。   The cell separation device according to any one of claims 1 to 3, wherein the separation unit, the holding unit, and the gripping unit are made of a metal member that can withstand autoclaving.
JP2008115590A 2008-04-25 2008-04-25 Cell separation device Active JP5164104B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008115590A JP5164104B2 (en) 2008-04-25 2008-04-25 Cell separation device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008115590A JP5164104B2 (en) 2008-04-25 2008-04-25 Cell separation device

Publications (2)

Publication Number Publication Date
JP2009261329A true JP2009261329A (en) 2009-11-12
JP5164104B2 JP5164104B2 (en) 2013-03-13

Family

ID=41387996

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008115590A Active JP5164104B2 (en) 2008-04-25 2008-04-25 Cell separation device

Country Status (1)

Country Link
JP (1) JP5164104B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102660455A (en) * 2012-05-15 2012-09-12 陈子江 Testis live sperm collector
WO2018048209A1 (en) * 2016-09-08 2018-03-15 Jeil Pharmaceutical Co., Ltd. Apparatus for ultrathin-cutting cell colonies or tissues and a fragmenting method using the same
CN107858290A (en) * 2017-12-28 2018-03-30 中国医科大学 A kind of mouse ovarian separation and egg mother cell culture apparatus
JPWO2018003476A1 (en) * 2016-06-30 2019-01-17 富士フイルム株式会社 Cell suspension membrane separation method and cell culture apparatus

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JPN6012015502; Bellco Glass社 ホームページ,[検索日:2012.03.12],<URL:http://www.bellcoglass.com/product_details.a *
JPN6012015503; Eur J Cancer Cli Oncol, (1988), vol.24, no.3, p.449-454 *
JPN6012015504; J Exp Med, (1982), vol.156, no.3, p.677-689 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102660455A (en) * 2012-05-15 2012-09-12 陈子江 Testis live sperm collector
JPWO2018003476A1 (en) * 2016-06-30 2019-01-17 富士フイルム株式会社 Cell suspension membrane separation method and cell culture apparatus
US11492578B2 (en) 2016-06-30 2022-11-08 Fujifilm Corporation Membrane separation method of cell suspension, and cell culture device
WO2018048209A1 (en) * 2016-09-08 2018-03-15 Jeil Pharmaceutical Co., Ltd. Apparatus for ultrathin-cutting cell colonies or tissues and a fragmenting method using the same
CN107858290A (en) * 2017-12-28 2018-03-30 中国医科大学 A kind of mouse ovarian separation and egg mother cell culture apparatus

Also Published As

Publication number Publication date
JP5164104B2 (en) 2013-03-13

Similar Documents

Publication Publication Date Title
JP5164104B2 (en) Cell separation device
Takaki et al. HLA-A* 0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes
Schaaf et al. Tuberculosis e-book: A comprehensive clinical reference
Stonos et al. Immunogenetics of small ruminant lentiviral infections
JP2018538000A5 (en)
Pálfi et al. Unusual spinal tuberculosis in an Avar Age skeleton (Csongrád-Felgyő, Ürmös-tanya, Hungary): A morphological and biomolecular study
Richards et al. Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutinin
Klessing et al. Cd4+ T cells induced by tuberculosis subunit vaccine h1 can improve the hiv-1 env humoral response by intrastructural help
Borthwick et al. Novel nested peptide epitopes recognized by CD4+ T cells induced by HIV-1 conserved-region vaccines
Pérez-Yanes et al. The characteristics of the HIV-1 env glycoprotein are linked with viral pathogenesis
Mizuguchi et al. Anti-HIV screening for cell-penetrating peptides using chloroquine and identification of anti-HIV peptides derived from matrix proteins
Berglund et al. Extended Cleavage Specificity of the Rat Vascular Chymase, a Potential Blood Pressure Regulating Enzyme Expressed by Rat Vascular Smooth Muscle Cells
KR20120032297A (en) Bottom frame of net fixation for cultivation of underwater organism
Valenzuela-Fernández et al. Contribution of the HIV-1 envelope glycoprotein to AIDS pathogenesis and clinical progression
Kumar et al. End-stage renal disease care in South Asia: demographics, economics, and opportunities
EP2527359A3 (en) Diagnostic assay
US20180217161A1 (en) Generation of cfdna reference material
Racine et al. HLA-DQ8 Supports Development of Insulitis Mediated by Insulin-Reactive Human TCR-Transgenic T Cells in Nonobese Diabetic Mice
Park et al. Emergence of the D614A mutation in the spike protein of SARS-CoV-2: Imported cases to the South Korea
Havas et al. 40: Supporting people with chronic kidney disease to self-manage: What do the patients want?
Laing et al. B21 GENETICS, GENOMICS, AND GENE EXPRESSION IN ASTHMA AND COPD: Children With An Acute Respiratory Illness Infected With Human Rhinovirus (rv) Species C, That Have A Cdhr3 Rs6967330 A Allele, Are More Likely To Have A Recurrent Wheezing Hospital Presentation
Richardt T cell epitope variation and cellular immune responses to autologous isolates in therapy-naive HIV-infected individuals.
Dagani NanoSpace 2000: Melding two worlds
McDowell Joint European plan will tackle Africa's killer diseases
Jo et al. Baseline Pulmonary Function Test Predicts Survival: Analysis From The Australian Ipf Registry

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110121

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20120314

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120327

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120521

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20121113

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20121212

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20151228

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 5164104

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250